Showing 1–12 of 18 results
Catatonia as Presenting Manifestation of Behavioral Frontotemporal Dementia: Insight From a PET/MRI Study
In this report, the authors discuss a case of behavioral frontotemporal dementia presenting with catatonia and describe brain functional modifications after drug treatment investigated with PET/MRI.
Self-isolation measures, while important in curbing the spread and impact of COVID-19, are likely to increase rates of anxiety and depression. Here, a case is presented of COVID-19–related anxiety leading to late-onset psychotic and catatonic depression.
Partially Treated Catatonia and Incipient Neuroleptic Malignant Syndrome: A Challenging Presentation
Neuroleptic malignant syndrome (NMS) is a life-threatening condition associated with use of psychotropic medications. This report presents a case of incipient NMS in a patient who developed catatonia during treatment with lorazepam and paliperidone.
Neuropsychiatric Complications of Immunosuppressants: A Case Report of Tacrolimus-Induced Catatonia in a Liver Transplant Recipient
Recognition and treatment of catatonia is imperative to decrease morbidity and mortality. The authors of this report discuss a patient who exhibited features consistent with catatonia following treatment with tacrolimus, an immunosuppressant.
What happens when the system meant to save you is killing you? This case follows a patient with neuroleptic malignant syndrome who continued to be administered the very drugs causing his condition. When he finally got to physicians who could treat him correctly, legal roadblocks prevented them from doing so.Â
Rapid Development of Lorazepam Tolerance Within 48 Hours in an Adult With Intellectual Disability Who Presented With Stuporous Catatonia and Refused Electroconvulsive Therapy
Benzodiazepine tolerance after multiple days or weeks has been described—but not within 48 hours. Read this report of a man with catatonia who rapidly developed tolerance to lorazepam in a short period of 48 hours.
Cerebral venous sinus thrombosis (CVST) may be a rare underlying cause of catatonia. Here, read about a 37-year-old woman with a history of systemic lupus erythematosus and antiphospholipid syndrome and a prior history of deep vein thrombosis who presented with catatonia secondary to CVST. How would you treat this patient?
Have you ever wondered what is responsible for an altered mental status with abnormal movements? Have you been uncertain about when and how to evaluate a patient with such signs and symptoms? Have you been perplexed by how to treat such an individual over the short and long term? If you have, then this article from our Rounds in the General Hospital section should prove useful.
Catatonia is a neuropsychiatric condition characterized by physical presentations ranging from profound immobility to excessive motor activity. The disorder occurs as a clinical expression of many different psychiatric, neurologic, or medical diagnoses. This update provides practical information on catatonia including its history, diagnostic considerations, and treatment recommendations.
Aside from the psychiatric manifestations, catatonia can be accompanied by medical comorbidities such as urinary retention. Read about a case of urinary retention associated with catatonia in which both conditions responded to benzodiazepine treatment.